9999999997-12-015711.txt : 20121231 9999999997-12-015711.hdr.sgml : 20121231 20121231102529 ACCESSION NUMBER: 9999999997-12-015711 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20121231 DATE AS OF CHANGE: 20121231 20121231 20121231 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OPTIMER PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001142576 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330830300 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 001-33291 FILM NUMBER: 121292623 BUSINESS ADDRESS: STREET 1: 101 HUDSON STREET STREET 2: SUITE 3501 CITY: JERSEY CITY STATE: NJ ZIP: 07302 BUSINESS PHONE: (201) 333-8819 MAIL ADDRESS: STREET 1: 101 HUDSON STREET STREET 2: SUITE 3501 CITY: JERSEY CITY STATE: NJ ZIP: 07302 CT ORDER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C0Q(#`@;V)J#3P\+TQI;F5AF4@-30O5'EP92]84F5F+U=;,2`R(#%=/CYS=')E86T-"FC>8F)D$&!@ M8F#R`A(,4X`$XPT@P1(.)-CK@<0G()>180=(EH$1G?C/./L/0(`!`-4Z!^0- M"F5N9'-T8F!@8&%@8(IF``*>"PRH@)$! M),O1@"S&`L4,##<8N!DX_P>W+(`JE=L+H9GBD!4;2D%$&44``@P`67T&UPT* M96YD7!E+U!A9V4^/@UE;F1O8FH--#0@,"!O8FH-/#PO1FEL=&5R+T9L871E M1&5C;V1E+T9I/N7%>M.R.%;\0]Z9+B)A^6R; MK1L6:3ZKRG8RJ7X]7!B3D(TI(00E>"3K+-L5VY=WBV*7-^PV_\GNJEU6OB?; M;;;+.5G`0/M?YQ>3:KOZLB#[O*WS=KGAMU6]R[:T==\QLD+PFS;;%LOK#S-M]]8S**^>+E*2=?I%P73VU5\^]])=K8JRNH$^M&EV-?_U@NJU51KOE] M45Z73>'?9T7=M---5L,G][^!W88N\L]9[Z",X?/G'RW26=3/.?'RY"#SJMTT M#]8F[%\"1R.*(F8,C`:'BHD3!H%19E$>F)$$H(U M)';/<-_'].ND7SN[CP&B46`C4GT#R)YJII2@I\&GZ9MC`A[N!,+.=1N0U;]@ M")5DAO`PA4O=.?NHGB`20P_==U*-"#@@6/C3_(`T`>;-`9.00@_ M"8?RZ'1O4CR&F$>2)2^_H+%_*;_QOOP*>Y[\OJF\^HCR)N*T\.KDI/">J;GP M/_8?:ZX6@WRBHJ!-)J.K'.NS)=?/)N1PP-E-E=R[4^$]"./3W"FU)<,>< M'\:2Y$KI;5Z:^[A0<76<>C$AI>U5T:MC($#AO5+N'A_Z2P%>84_&BJNAGPK7 M"=Y#>5!QT>^TXF+U)+A2OA)BM? MZZT.CF@,+-3]^X;P.7L_S[SD%2AZ]=M`&LB-1P.)SY MYIOAVZ)S<2=>O[ZX'=Q?/V8$*\3%:=BZ((A1+%AX[2 M(@AA&OY'82JRL"?S5!3+CB?\XI_.U2TNKA0JJS`4@9(J$<7E$4EM)8L?CTA$ M3I<,PT@4$["$WSZ+())Y;K>8=IZ\1S_QAO"[\;577%W"FWCP`^45?7@MKA[\ MOXI?P"A0$N+Z3.8]?)L>V3NV>].6FM;Q"^RM8IFE]W_A! MY!4XH#>:)@'1'UX*&O[IJ]`;_.P'L=6/P5DSS&_B)2'6%#I6FK7HR M/.FMU'E+:QG&U6:'Q;,3SDUDGM2-I0/?7Y*#[@7ZZKX/EH;>L'(QN5#0++MP M>.WG_(D7UF3[OY*K:>(>/JK$Z],`/6Z%F^[5L0SS4\?OG0(+K&YX_W%H#T/; M$@@X_+3M-X.)@;0/HOZ`Q`4Y`OT@E!]H+\='A(]X_WB).G6\W!TO"J5.SD57 M.5)12L:J%4SMK=&PK1]YPCE"F+,H4Q?/(&?I![US^T M8ULA5_=R4ME+*_U[)W24&^12UQWRGOYHY?OFWPEMCD2AG"@N)X'2,F,(12<\ MG1PM(W3XV!X^QD,:#S;A!:"8,W80-1N$A+A#9G6X4OP-<068>]XUUTT04BE! M*O&Z^(VQ>>.K',$%7#F1/-UT^1/#<#=>HC6$B:U[(#"F8@3/%3W7ZX638B#[ M,4O25+D2N]64.3DR.WGWZ`:=R#2WY]Y5H-/QF*4,`27(Y[B;E54J)^G%J2_-QN(.9;@6N_X'?<>8%VV1WQ/RG< M&*7+_;B07V?DIBLXRA>*YVSN][QQ%:876@;^2/1>SC5A]\1H*0D$(]Z.Q%(K MEK+8=MME# M@A::_0D?SY0&IOQO]OJD!O4`_Z=FS#8RKKK,5IKG%$_*$\Q0-0PJE$J=9=[L M*!^XY'_K9Y0]E'V5%S#&F#PXLX889/3FA%84]';6X6?@BS&M_NKKT,9L/W60 M=4`S`9ZP36B^(ZCYJ#F(&*.-<;XN$,O5G3F8.G\+5QX!!;FI,IVRG*#XZPX7[SA&4CHK+!AIW8K^]K.AE-=J&+?X0)^8!AEU#D M08T42:+?>:!A_,Z')[W&]-K=,Q&;?5+]:>Y:)+L5&SE`8B*#UO36[`VPR,V"QD25G;>MAJNK@BM.R\LJJ)$DVNA3KW;A>#BE.$*&O?@0).*WL MG]@0EIRH9$A%X5(X)Q)RT`A>S;;_C;HQ.N)V9"Q$5Z5CF<5V#DF%Z4"/#E_"\(Y#.JHJH'&K,7>1V1%WSUY9O$JD: MS82G>J9[T*%*N%_-TA8F#YES8!!`8%NN/"[<=K(.JXO=N8!HM1>0`YGC_'8- MCC\`VH'6!E7$!7VI& MKD1;SK8HH-`#&:.]-VN8WW@#&]'4@N>5 MZ43SDS'5+J:9S+.S88WVPKHG$I\72;X_6[\YJ2F$,^='*DE3&VCBY,HDP,"0FU=2Y![D&!D1&:7`?IZ! MC8&9`0P2DXL+'`,"?$#LO/R\5`8,\.T:`R.(OJP+,@M3'B]@32XH*@'2!X#8 M*"6U.!E(?P'BS/*2`J`X8P*0+9*4#6:#U(EDAP0Y`]D=0#9?26H%2(S!.;^@ MLB@S/:-$P=#2TE+!,24_*54AN+*X)#6W6,$S+SF_J""_*+$D-06H%FH'"/"[ M%R56*K@GYN8F*ACI&9'H<&R(D[(NB:NL+)XXAI9!FP/63,)>`*(@"=%I'D74A4DX$7L1\"+ M,9&`%Q..!5[A<3#PBNCIXL+=X,B>MF[3C+F;]F/../[?$^O\,MWD5PINVS_F M+\T`-7/'_G7(;C>-I\/2MNW[:;6:D;>PA8;9UA*B$34*C5(C:50:"WBVM812 M6"FL%%8**X65PDIAI;!21"FB%%&**$64(DH1I8A29*'Q;8YC\_0V'/OAJAE^ M#3]U]_@WN_7\N8:]WZ//W6/;Y=U#`\/G[J^G:9[356"]_9'[TW0>GKX_'\9V M>!L.>?QS8H\;_-"_N$ML[5MWG\+U6 MEG)E4WI.5&-Z:V,Y9"(_/@H\>#IX;7!M971A('AM;&YS.G@](F%D M;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!835`@0V]R92`U+C(M8S`P M,2`V,RXQ,SDT,SDL(#(P,3`O,#DO,C&UP.DUE=&%D871A M1&%T93XR,#$R+3$R+3,Q5#$P.C(S.C$T+3`U.C`P/"]X;7`Z365T861A=&%$ M871E/@H@("`@("`@("`\>&UP.D-R96%T;W)4;V]L/D%C&UP.D-R96%T;W)4;V]L/@H@("`@("`\+W)D M9CI$97-C&UL;G,Z>&UP34T](FAT='`Z+R]N&%P+S$N,"]M;2\B/@H@("`@("`@("`\>&UP34TZ1&]C=6UE;G1) M1#YU=6ED.C$Y9&9B-6(Y+3`P934M-&%D.2UA.30T+69C8V5E9#5F8C@W-CPO M>&UP34TZ1&]C=6UE;G1)1#X*("`@("`@("`@/'AM<$U-.DEN&UL;G,Z M9&,](FAT='`Z+R]P=7)L+F]R9R]D8R]E;&5M96YT&UL;G,Z<&1F/2)H='1P.B\O;G,N861O8F4N8V]M M+W!D9B\Q+C,O(CX*("`@("`@("`@/'!D9CI02`Q,"XP/"]P9&8Z4')O9'5C97(^"B`@("`@(#POV?Z!]/(+781MJ"E*EBN: M'#BY2HR,$X4JO7*0FJ+C&D?V%UK%1ZAVN[<``P`)S$=Y#0IE;F1S=')E86T- M96YD;V)J#34@,"!O8FH-/#PO1&5C;V1E4&%R;7,\/"]#;VQU;6YS(#0O4')E M9&EC=&]R(#$R/CXO1FEL=&5R+T9L871E1&5C;V1E+TE$6SQ!.4,U13DR0C,R M,4-&0S0Q.#7!E+UA2968O5ULQ(#(@,5T^/G-T